An appeals court decision imposing antitrust liability on patent-infringement litigants for settling their suit departs dramatically from US Supreme Court precedent and, if not overturned, will lead to fruitless legal battles with no consumer benefit.
from Forbes Real Time https://www.forbes.com/sites/wlf/2017/10/23/third-circuit-antitrust-decision-makes-pharmaceutical-patent-disputes-nearly-impossible-to-settle/
via IFTTT
No comments:
Post a Comment